Who doesn't love passive income? As investors, we love dividend stocks, especially the ones that have high yields since they provide a steady source of income and improve the total return potential.
Today, we'll be highlighting PFE, YORW, and UPS. The trio offers a market-crushing 5.8% yield, an A- blended S&P credit rating, and is trading 21% below fair value estimates. Pfizer appears to have the product portfolio and pipeline to return to modest growth. The York Water Company's capex spending and bolt-on acquisitions can fuel future growth.
Pfizer and partner BioNTech said on Monday their updated COVID-19 vaccine showed an increased immune response in adults aged 65 and older as well as those aged 18 through 64 with at least one underlying risk condition.
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced positive topline results from an ongoing Phase 3 clinical trial cohort evaluating the safety, tolerability, and immunogenicity of a 30-µg dose of the LP.8.1-adapted monovalent COMIRNATY® (COVID-19 Vaccine, mRNA) 2025-2026 Formula in adults aged 65 and older an...
Pfizer (PFE 1.28%) is a fairly well-known drugmaker, with a name that even non-healthcare-oriented types would likely know. That's a testament to the company's longevity and its success as a business.
Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.